Reliability and reproducibility of vertical diffusion cells for determining release rates from semisolid dosage forms

Pharmaceutical Research

Volumn 24, Issue 11, 2007, Pages 2018-2024

  Hauck, Walter W ^a   Shah, Vinod P ^a   Shaw, Steven W ^b   Ueda, Clarence T ^c  

^a UNITED STATES PHARMACOPEIA   (United States)

^b Hanson Research Corporation   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Franz Cell; Performance qualification; Performance verification test; Semisolid dosage forms

Indexed keywords

BETAMETHASONE DIPROPIONATE; HYDROCORTISONE;

ACCURACY; ARTICLE; CREAM; DIFFUSION; DRUG DOSAGE FORM; DRUG INDUSTRY; DRUG RELEASE; GEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LABORATORY; MOLECULAR MODEL; OINTMENT; PRIORITY JOURNAL; RELIABILITY; REPRODUCIBILITY; SOLID; TRAINING;

DIFFUSION CHAMBERS, CULTURE; DOSAGE FORMS; MEMBRANES, ARTIFICIAL; PHARMACEUTICAL PREPARATIONS; REPRODUCIBILITY OF RESULTS; SOLUBILITY; TECHNOLOGY, PHARMACEUTICAL;

EID: 34848868142     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-007-9329-x     Document Type: Article

References (9)

1. V. P. Shah and C. T. Ueda. USP advisory panel on the USP performance test for topical and transdermal dosage forms. Pharm. Forum. 32:1584-1595 (2006).
2. National Institute of Standards and Technology. Guidance on federal conformity assessment activities. Fed. Regist. 65:48894-48902 (2000).
3. FDA. Guidance for industry: Text on validation of analytical procedures. U.S. Department of Health and Human Services, Washington, DC, (1995). http://www.fda.gov/cder/guidance/ichq2a.pdf (accessed 09 April 2007).
4. International Organization for Standardization. ISO/IEC Guide 43-1: Proficiency Testing by Interlaboratory Comparisons. ISO, Geneva, Switzerland, (1997).
5. G. L. Flynn, V. P. Shah, S. N. Tenjarla, M. Corbo, D. DeMagistris, T. G. Feldman, T. J. Franz, D. R. Miran, D. M. Pearce, J. A. Sequeira, J. Swarbrick, J. C. T. Wang, A. Yacobi, and J. L. Zatz. Workshop report: assessment of value and application of in vitro testing of topical dermatological drug products. Pharm. Res. 16:1325-1330 (1999).
6. V. P. Shah, J. S. Elkins, and R. L. Williams. Evaluation of the test system used for in vitro release of drugs for topical dermatological drug products. Pharm. Dev. Technol. 4:377-385 (1999).
7. FDA. SUPAC-SS nonsterile semisolid dosage forms, scale-up and postapproval changes: chemistry, manufacturing, and controls; in vitro release testing and in vivo bioequivalence documentation. U.S. Department of Health and Human Services, Washington, DC (1997). http://www.fda.gov/cder/guidance/1447fnl. pdf (accessed 09 April 2007).
8. C. T. Ueda, V. P. Shah, J. Derdzinski, G. Ewing, G. Flynn, H. Maibach, M. Marques, S. Shaw, K. Thakker, and A. Yacobi. Performance test for topical and transdermal dosage forms. Pharm. Forum. 32:1586-1589 (2006).
9. V. P. Shah, J. Elkins, S. Shaw, and R. Hanson. In vitro release: comparative evaluation of vertical diffusion cell system and automated procedure. Pharm. Dev. Technol. 8:97-102 (2003).